RCT | Gefitinib plus MTX not better than MTX alone to treat tubal ectopic pregnancy

Combination of gefitinib and methotrexate to treat tubal ectopic pregnancy (GEM3): a multicentre, randomised, double-blind, placebo-controlled trial – The Lancet

Commentary from the author on Twitter (thread – click for more)

See our @Gem3Study in @TheLancet: no benefit of adding gefitinib to methotrexate to treat #ectopic pregnancy but important data to inform guidelines on clinical outcomes after methotrexate https://t.co/xgtA4oLBJd @ProfStephenTong @GynaeResearcher @TheEPT @MRC_CRH @EdinUniMedia pic.twitter.com/g96Z8B400a

— Andrew Horne (@horne_research) February 2, 2023

Under a Creative Commons Attribution (CC BY 4.0) license